Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
4.930
+0.060 (1.23%)
At close: May 16, 2025, 4:00 PM
4.940
+0.010 (0.20%)
After-hours: May 16, 2025, 6:23 PM EDT
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $74.06 million as of May 16, 2025. Its market cap has decreased by -79.54% in one year.
Market Cap
74.06M
Enterprise Value
27.85M
1-Year Change
-79.54%
Ranking
Category
Stock Price
$4.93
Market Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has decreased from $122.75M to $74.06M, a decrease of -39.67%. That is a compound annual growth rate of -9.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 74.06M | -76.91% |
| Dec 31, 2024 | 320.73M | 264.33% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | 125.13M | 1.93% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 658.30B |
| Johnson & Johnson | 359.97B |
| AbbVie | 320.92B |
| Novo Nordisk | 289.00B |
| UnitedHealth Group | 248.87B |
| Abbott Laboratories | 232.01B |
| Novartis AG | 211.47B |
| AstraZeneca | 208.86B |